Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthPRNewsWire • 09/16/24
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial ResultsGlobeNewsWire • 08/07/24
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share PaymentsGlobeNewsWire • 07/17/24
OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/08/24
OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsGlobeNewsWire • 05/07/24
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessPRNewsWire • 03/28/24
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIVGlobeNewsWire • 03/05/24
OPKO Health (OPK) Reports Q4 Earnings: What Key Metrics Have to SayZacks Investment Research • 02/28/24
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial ResultsGlobeNewsWire • 02/27/24
Gear Up for OPKO Health (OPK) Q4 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 02/26/24
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024GlobeNewsWire • 02/22/24